175. RSV: Not Just a Childhood Disease
Friday, October 28, 2016: 2:00 PM-3:30 PM
Room: 278-282

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the epidemiology of respiratory syncytial virus (RSV)
  • discuss the status of RSV vaccines
  • understand how antivirals can be used for RSV

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Members-in-training, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Adult ID, Pediatric ID, Epidemiology and Infection Control

Moderators:  Susan Gerber, MD, Centers for Disease Control and Prevention and Inger Damon, MD, PhD, FIDSA, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases

2:00 PM
2:30 PM
RSV Antivirals
John P. Devincenzo, MD

3:00 PM
RSV Vaccine Development
Ruth Karron, MD, FIDSA

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours .15 of pharmacy CE

ACPE Number: 0221-9999-16-271-L01-P


S. Gerber, None

I. Damon, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.